Smith & Nephew (NYSE:SNN) said today that it agreed to put $660 million on the table to acquire Osiris Therapeutics (NSDQ:OSIR) and its regenerative medicine portfolio. The British orthopedics and wound care giant said the $19-per-share deal is a 37% premium on the 90-day volume-weighted average for OSIR shares. It’s structured as a two-step tender […]
MiMedx escapes Osiris trade theft suit
MiMedx (NSDQ:MDXG) enjoyed a rare spot of good news when a federal judge in Maryland this week dismissed a trade theft and breach-of-contract lawsuit brought by Osiris Therapeutics over MiMedx’s Stability Biologics acquisition. Columbia, Md.-based Osiris said it inked a distribution deal back in 2013 to have Stability sell a pair of its products through the end of 2015. But after […]
Osiris levels $7m trade theft, breach-of-contract suit against MiMedx over Stability Biologics deal
Osiris Therapeutics leveled trade theft and breach-of-contract charges worth nearly $7 million against a regenerative medicine rival, stemming from the Stability Biologics acquisition by MiMedx (NSDQ:MDXG). Columbia, Md.-based Osiris said it inked a distribution deal back in 2013 to have Stability sell a pair of its products through the end of 2015. But after MiMedx paid $10 million for […]
Osiris wins positive review from BCBSA for Grafix
Osiris Therapeutics said today the Blue Cross Blue Shield Association gave the company’s Grafix a positive review when used to treat individuals with diabetic lower-extremity ulcers. Gravix is a cryopreserved placental membrane designed as a wound cover for patients with chronic wounds, and can conform and be applied directly to acute and chronic wounds, the company […]
Ex-Monarch Medical CEO Wilson lands at Nihon Kohden | Personnel Moves
Stryker debuts Osiris bone putty
Osiris strikes deal with Stryker for bone-repair product
Acelity snares Smith & Nephew exec Agarwal | Personnel Moves
Stryker taps new medical chief
Stryker (NYSE:SYK) tapped Dr. Scott Bruder, a Becton Dickinson & Co. (NYSE:BDX) veteran, to fill its newly created chief medical & scientific officer position.
Medtronic home healthcare system cuts costs: Study | Research roundup
Medtronic Inc. (NYSE:MDT) said the results of a clinical trial for its new remote monitoring network indicate that the system reduces healthcare costs.
The study showed that monitoring of implantable cardiac device patients with the Medtronic’s CareLink network and CareAlert notification system cuts down on healthcare utilization costs when compared to in-office follow-up appointments, according to the company.
Orthofix streamlines, settles infringement suit
UPDATE: Dec. 17, 3:57 p.m.
Orthofix International NV (NSDQ:OFIX) is streamlining its operations, aiming to save up to $7 million a year.
MassDevice Network
@MassDevice
LinkedIn
YouTube